Reaction
Breast Calcifications reporting signals
As of the last recalculation, Breast Calcifications appears in 792 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE (PRR 49.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Conjugated Estrogens And Medroxyprogesterone Acetate | 42 | 49.3 | 49.4 |
| Alendronate Sodium | 118 | 35.9 | 36.0 |
| Conjugated Estrogens | 56 | 27.1 | 27.1 |
| Estrogens, Conjugated | 56 | 26.6 | 26.6 |
| Raloxifene Hydrochloride | 13 | 23.8 | 23.8 |
| Medroxyprogesterone Acetate | 40 | 22.2 | 22.2 |
| Asfotase Alfa | 5 | 13.2 | 13.2 |
| Teriparatide | 36 | 8.7 | 8.7 |
| Abaloparatide | 7 | 6.3 | 6.3 |
| Ranitidine Hydrochloride | 11 | 5.4 | 5.4 |